Hisamitsu Pharmaceutical Co., Inc. (4530.T) JPX

4,128.00

+66(+1.62%)

Updated at October 03 03:30PM

Currency In JPY

Hisamitsu Pharmaceutical Co., Inc.

Address

408, Tashiro Daikan-machi

Tosu, 841-0017

Japan

Phone

81 3 5293 1720

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2759

First IPO Date

January 01, 2001

Key Executives

NameTitlePayYear Born
Mr. Kazuhide NakatomiPresident, Chief Executive Officer & Director01972
Mr. Nobuo TsutsumiExe Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director01964
Mr. Kosuke SugiyamaExecutive MD of Human Resources, Research & Development, Corporate Planning and Director01952
Masaya OkunoSenior Executive Officer and GM of the Pharmaceuticals & Cosmetics Division0N/A
Tetsuo AkiyamaSenior Managing Executive Officer, Head of Business Operations & Head of BU0N/A
Mr. Shinichi MurayamaExecutive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director01967
Mitsutoshi TsurutaSenior Executive Officer & GM of Pharmaceutical Business Division0N/A
Mr. Koji TakiyamaExecutive Officer, GM of President's Office, Digital Transformation Officer & Director01971
Mr. Kyu SaitoMD, Executive Officer, GM of Global Business & Director01963
Mr. Naruhito HigoExecutive Vice President & Head of Global Technology0N/A

Description

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.